tiprankstipranks
Lavipharm S.A. (DE:BXA0)
FRANKFURT:BXA0
Germany Market

Lavipharm S.A. (BXA0) Financial Statements

0 Followers

Lavipharm S.A. Financial Overview

Lavipharm S.A.'s market cap is currently €280.42M. The company's EPS TTM is €; its P/E ratio is 46.42; and it has a dividend yield of 2.39%. Lavipharm S.A. is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 62.58M€ 52.95M€ 50.93M€ 39.06M€ 39.72M
Gross Profit€ 28.80M€ 23.73M€ 23.20M€ 16.38M€ 14.69M
Operating Income€ 7.16M€ 4.26M€ 4.18M€ 2.69M€ -398.00K
EBITDA€ 12.38M€ 10.27M€ 9.73M€ 5.60M€ 6.23M
Net Income€ 5.99M€ 8.98M€ 1.87M€ 834.00K€ 1.72M
Balance Sheet
Cash & Short-Term Investments€ 6.11M€ 5.59M€ 8.44M€ 18.24M€ 1.64M
Total Assets€ 130.68M€ 125.68M€ 114.85M€ 114.35M€ 52.98M
Total Debt€ 28.37M€ 33.82M€ 32.37M€ 37.07M€ 37.33M
Net Debt€ 22.26M€ 28.23M€ 23.94M€ 16.13M€ 35.69M
Total Liabilities€ 74.27M€ 72.71M€ 72.08M€ 74.04M€ 62.92M
Stockholders' Equity€ 56.42M€ 52.98M€ 42.74M€ 40.28M€ -9.98M
Cash Flow
Free Cash Flow€ 2.10M€ -4.85M€ -3.58M€ -32.25M€ 1.92M
Operating Cash Flow€ 6.72M€ 4.80M€ 539.00K€ 3.37M€ 3.84M
Investing Cash Flow€ -993.00K€ -9.66M€ -3.71M€ -35.61M€ -1.91M
Financing Cash Flow€ -5.35M€ 2.16M€ -6.63M€ 48.85M€ -2.23M
Currency in EUR

Lavipharm S.A. Earnings and Revenue History

Lavipharm S.A. Debt to Assets

Lavipharm S.A. Cash Flow

Lavipharm S.A. Forecast EPS vs Actual EPS